• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by HCA Healthcare Inc.

    2/18/25 8:44:06 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care
    Get the next $HCA alert in real time by email
    8-K
    false 0000860730 0000860730 2025-02-18 2025-02-18

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): February 18, 2025

     

     

    HCA Healthcare, Inc.

    (Exact Name of Registrant as Specified in its Charter)

     

     

     

    Delaware   001-11239   27-3865930

    (State or Other Jurisdiction

    of Incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    One Park Plaza

    Nashville, Tennessee

      37203
    (Address of Principal Executive Offices)   (Zip Code)

    (615) 344-9551

    (Registrant’s Telephone Number, Including Area Code)

    Not Applicable

    (Former Name or Former Address, if Changed Since Last Report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

      ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

      ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

      ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

      ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each Class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, $.01 par value per share   HCA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 8.01.

    Other Events.

    On February 18, 2025, HCA Healthcare, Inc. (the “Company”) issued a press release (the “Press Release”) announcing the commencement of its proposed public offering by HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of the Company, of senior unsecured notes (the “Offering”). The text of the Press Release is set forth as Exhibit 99.1 and is incorporated herein by reference. In connection with the Offering, the Company is disclosing certain information, as set forth below.

    As of February 14, 2025, the Issuer has borrowed $2.950 billion under the ABL credit facility (as defined below), a portion of which was used to repay at maturity all $2.600 billion of its 5.375% Senior Notes due 2025.

    Prior to the closing of the Offering, the Issuer intends to enter into the New Credit Agreement (as defined below), and, substantially contemporaneously therewith, the Issuer intends to terminate all outstanding commitments and repay all outstanding obligations under (i) that certain credit agreement, dated as of November 17, 2006, as amended and restated on May 4, 2011, February 26, 2014, June 28, 2017, June 30, 2021 and January 4, 2023, among the Issuer, the guarantors party thereto, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent, collateral agent, swingline lender and letter of credit issuer (the “Cash Flow credit facility”) and (ii) that certain credit agreement, dated as of September 30, 2011, as amended and restated on March 7, 2014, June 28, 2017 and June 30, 2021 and as amended on January 4, 2023, among the Issuer, the subsidiary borrowers party thereto, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent, collateral agent, swingline lender and letter of credit issuer (the “ABL credit facility” and together with the Cash Flow credit facility, the “senior secured credit facilities”).

    The Cash Flow credit facility provides for a $3.500 billion senior secured revolving credit facility and a senior secured term loan A facility with $1.238 billion outstanding as of December 31, 2024. The ABL credit facility provides for a $4.500 billion senior secured revolving credit facility. The Issuer intends to prepay all outstanding borrowings under the senior secured credit facilities immediately prior to their termination. Absent termination, such senior secured credit facilities mature on June 30, 2026. Borrowings under the senior secured credit facilities bear interest at a fluctuating rate per annum equal to, at the Issuer’s option, the alternate base rate or the Term Secured Overnight Financing Rate (“Term SOFR”), in each case, plus an applicable margin that is calculated based on the Issuer’s leverage ratio from time to time, plus a credit spread adjustment.

    The Issuer intends to refinance the senior secured credit facilities by entering into a new credit agreement with the lenders party thereto and Bank of America, N.A., as administrative agent, collateral agent, swingline lender and letter of credit issuer (the “New Credit Agreement”) that will provide for $8.000 billion of senior unsecured revolving credit commitments, with a term of five years (the “senior unsecured credit facility”). The proceeds of any borrowings under the senior unsecured credit facility will be used for general corporate purposes. The substantially concurrent termination of the senior secured credit facilities is a condition to entering into the New Credit Agreement.

    The New Credit Agreement will contain affirmative and negative covenants customary for credit facilities of its type, including, among others, limitations on the Issuer and its subsidiaries with respect to liens, incurrence of indebtedness by subsidiaries of the Issuer, and certain fundamental changes. The senior unsecured credit facility will not be guaranteed by the Company or by any subsidiary of the Issuer.

    The Issuer will be subject to a financial covenant under the New Credit Agreement, tested quarterly, whereby the leverage ratio may not exceed 4.50:1.00 (with a step-up, upon the Issuer’s election, to 5.00:1.00 during certain specified periods following a material acquisition).

    Borrowings under the senior unsecured credit facility will bear interest at a fluctuating rate per annum equal to, at the Issuer’s option, the alternate base rate or Term SOFR, in each case, plus an applicable margin that will be calculated based on the Issuer’s credit rating from time to time, plus a credit spread adjustment. The Issuer currently expects that borrowings under the senior unsecured credit facility will initially bear interest at a rate per annum equal to Term SOFR plus 1.250% (plus a 0.10% credit spread adjustment).


    The New Credit Agreement will also provide for, as part of the $8.000 billion senior unsecured credit facility, (x) borrowings in euros and pound sterling, up to a $400.0 million sublimit, (y) letters of credit, up to a $750.0 million sublimit and (z) swingline loans, up to a $250.0 million sublimit. Each of these sub-facilities will provide the same capacity with respect to foreign currency borrowings, letters of credit and swingline loans as is available to the Issuer under the senior secured credit facilities.

    In order to repay obligations outstanding under the senior secured credit facilities, the Issuer intends to borrow under the senior unsecured credit facility. The Issuer intends to use the net proceeds from the Offering for general corporate purposes, which may include the repayment of expected borrowings under the proposed senior unsecured credit facility (such transactions, collectively, the “Proposed Refinancing Transaction”). If the Proposed Refinancing Transaction is not consummated, these general corporate purposes may instead include the repayment of borrowings outstanding under the ABL credit facility.

    Forward-Looking Statements

    Information provided and statements contained in this report that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements only speak as of the date of this report and the Company assumes no obligation to update the information included in this report. Such forward-looking statements include statements regarding the Offering, the Proposed Refinancing Transaction and the expected use of proceeds from the Offering. These statements often include words such as “approximate,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These forward-looking statements are not historical facts, and are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond the Company’s control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance or occurrence of events and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. More information about potential risks and uncertainties that could affect the Registrant’s business and results of operations is included in the “Risk Factors” and “Forward-Looking Statements” sections in the Annual Report on Form 10-K filed by the Company with the SEC on February 14, 2025. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this report.

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits:

     

    Exhibit

     No. 

       Description
    99.1    Press Release, dated February 18, 2025
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    HCA HEALTHCARE, INC. (Registrant)
    By:  

    /s/ John M. Franck II

      John M. Franck II
      Vice President - Legal and Corporate Secretary

    Date: February 18, 2025

    Get the next $HCA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCA

    DatePrice TargetRatingAnalyst
    12/15/2025$425.00Equal-Weight → Underweight
    Morgan Stanley
    10/14/2025$470.00Buy
    Goldman
    7/28/2025Outperform → Peer Perform
    Wolfe Research
    7/16/2025$394.00Buy → Neutral
    BofA Securities
    5/29/2025$385.00Underweight → Equal Weight
    Wells Fargo
    4/15/2025$336.00Outperform → Neutral
    Robert W. Baird
    12/17/2024$380.00Neutral
    Analyst
    11/25/2024$400.00 → $320.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings

    $HCA
    SEC Filings

    View All

    SEC Form 10-K filed by HCA Healthcare Inc.

    10-K - HCA Healthcare, Inc. (0000860730) (Filer)

    2/10/26 4:27:54 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - HCA Healthcare, Inc. (0000860730) (Filer)

    1/27/26 7:12:53 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - HCA Healthcare, Inc. (0000860730) (Filer)

    10/31/25 4:15:19 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    HCA Healthcare Hospitals Named on America's 50 Best Hospitals List for 2026 by Healthgrades

    44 hospitals ranked among America's 250 Best Hospitals HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that three of its hospitals were named among America's 50 Best Hospitals and 15 of its hospitals were named among America's 100 Best Hospitals by Healthgrades. These are part of the 44 HCA Healthcare hospitals recognized on the Healthgrades America's 250 Best Hospitals list for 2026. Inclusion on these lists recognizes superior performance in providing care for conditions and procedures across multiple specialty lines and areas. Mission Hospital in Asheville, North Carolina, HCA HealthONE Sky Ridge in Lone Tree, Colorado and HCA Florid

    1/29/26 8:30:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Reports Fourth Quarter 2025 Results and Provides 2026 Guidance

    HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion Diluted earnings per share increased 44.6 percent to $8.14 per share, and diluted earnings per share, as adjusted, increased 28.8 percent to $8.01 per share Adjusted EBITDA increased 10.8 percent to $4.114 billion Cash flows from operating activities totaled $2.359 billion, compared to $2.559 billion in the fou

    1/27/26 7:00:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Names Erica Rossitto as Chief Nurse Executive

    HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Erica Rossitto, MBA/HCM, BSN, RN, NEA-BC, has been promoted to senior vice president and chief nurse executive, effective February 1, 2026. In this role, Rossitto will lead the nursing agenda in advancing the practice of nursing among HCA Healthcare's more than 100,000 nurses. "Erica is an accomplished and respected leader who brings a deep understanding of nursing and clinical operations to this role," said Sam Hazen, CEO of HCA Healthcare. "I'm confident her demonstrated ability to unite teams, strengthen nursing leadership and drive innovation will continue to help support nurses and

    1/15/26 8:30:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

    4 - HCA Healthcare, Inc. (0000860730) (Issuer)

    3/28/25 4:11:57 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HCA downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded HCA from Equal-Weight to Underweight and set a new price target of $425.00

    12/15/25 9:55:49 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    Goldman resumed coverage on HCA with a new price target

    Goldman resumed coverage of HCA with a rating of Buy and set a new price target of $470.00

    10/14/25 8:49:40 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA downgraded by Wolfe Research

    Wolfe Research downgraded HCA from Outperform to Peer Perform

    7/28/25 8:34:28 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Controller Wyatt Christopher F. was granted 3,350 shares, covered exercise/tax liability with 1,034 shares and sold $2,020,000 worth of shares (4,000 units at $505.00), decreasing direct ownership by 4% to 44,379 units (SEC Form 4)

    4 - HCA Healthcare, Inc. (0000860730) (Issuer)

    2/12/26 6:55:42 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    SVP & Chief Nurse Executive Rossitto Erica was granted 1,676 shares and covered exercise/tax liability with 418 shares, increasing direct ownership by 14% to 10,407 units (SEC Form 4)

    4 - HCA Healthcare, Inc. (0000860730) (Issuer)

    2/12/26 6:53:14 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    EVP & Chief Legal & Admin Off. Mcalevey Michael R was granted 8,372 shares and covered exercise/tax liability with 3,006 shares, increasing direct ownership by 154% to 8,853 units (SEC Form 4)

    4 - HCA Healthcare, Inc. (0000860730) (Issuer)

    2/12/26 6:51:40 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Financials

    Live finance-specific insights

    View All

    HCA Healthcare Reports Fourth Quarter 2025 Results and Provides 2026 Guidance

    HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion Diluted earnings per share increased 44.6 percent to $8.14 per share, and diluted earnings per share, as adjusted, increased 28.8 percent to $8.01 per share Adjusted EBITDA increased 10.8 percent to $4.114 billion Cash flows from operating activities totaled $2.359 billion, compared to $2.559 billion in the fou

    1/27/26 7:00:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare, Inc. 4th Quarter 2025 Earnings Conference Call

    HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What:   HCA Healthcare, Inc. 4Q 2025 Earnings Call When:   Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How:   Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://

    12/30/25 4:00:00 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Reports Third Quarter 2025 Results

    Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share Adjusted EBITDA increased 18.5 percent to $3.870 billion Cash flows from operating activities totaled $4.416 billion,

    10/24/25 7:00:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Leadership Updates

    Live Leadership Updates

    View All

    HCA Healthcare Presents 2025 Awards of Distinction

    HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction—comprising the Frist Humanitarian Award and the Excellence in Nursing Award—are the highest honors HCA Healthcare bestows on employees, physicians and volunteers, recognizing the extraordinary individuals who exemplify the organization's culture and values. The Frist Humanitarian Award recognizes the highest achievements in serving others, and the HCA Healthcare Excellence in Nursing Award recognizes the highest levels of performance in the field of nursing. "The

    9/30/25 4:30:00 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Appoints John W. Chidsey, III as New Independent Director

    HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare's board of directors increases from nine to ten members. Mr. Chidsey will serve as a member of HCA Healthcare's audit and compliance committee, compensation committee and patient safety and quality of care committee. Mr. Chidsey most recently served as the global chief executive officer of Subway. He previously served as chief executive officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier

    7/11/25 8:30:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs

    HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com

    9/19/23 8:30:00 AM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    $HCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

    SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

    2/14/24 5:10:03 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

    SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

    2/14/24 5:06:57 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

    SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

    2/13/24 5:06:27 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care